Dr. Redelman-Sidi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
530 East 74th Street
New York, NY 10021
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Infectious Disease, 2008 - 2011
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2004 - 2008
Tel Aviv University SacklerClass of 2000
Certifications & Licensure
FL State Medical License 2022 - Present
NY State Medical License 2007 - 2026
NJ State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 6 citationsSerial interferon-gamma release assay in lung cancer patients receiving immune checkpoint inhibitors: a prospective cohort study.Kohei Fujita, Paul Elkington, Gil Redelman-Sidi, Osamu Kanai, Yuki Yamamoto
Cancer Immunology, Immunotherapy. 2022-11-01 - 4 citationsBCG-Induced Tumor Immunity Requires Tumor-Intrinsic CIITA Independent of MHC-II.Gil Redelman-Sidi, Anna Binyamin, Anthony C Antonelli, Will Catalano, James Bean
Cancer Immunology Research. 2022-10-04 - 30 citationsBCG in Bladder Cancer Immunotherapy.Song Jiang, Gil Redelman-Sidi
Cancers. 2022-06-23
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
